List of Tables
Table 1. Global Market Noninvasive Cancer Diagnostics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Noninvasive Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Noninvasive Cancer Diagnostics Market Size Share by Region (2018-2023)
Table 4. Global Noninvasive Cancer Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Noninvasive Cancer Diagnostics Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Noninvasive Cancer Diagnostics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Noninvasive Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Noninvasive Cancer Diagnostics Revenue Market Share by Type (2018-2023)
Table 9. Global Noninvasive Cancer Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Noninvasive Cancer Diagnostics Revenue Market Share by Type (2024-2029)
Table 11. North America Noninvasive Cancer Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Noninvasive Cancer Diagnostics Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Noninvasive Cancer Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Noninvasive Cancer Diagnostics Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Noninvasive Cancer Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Noninvasive Cancer Diagnostics Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Noninvasive Cancer Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Noninvasive Cancer Diagnostics Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Noninvasive Cancer Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Noninvasive Cancer Diagnostics Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Noninvasive Cancer Diagnostics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Noninvasive Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Noninvasive Cancer Diagnostics Revenue Market Share by Application (2018-2023)
Table 24. Global Noninvasive Cancer Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Noninvasive Cancer Diagnostics Revenue Market Share by Application (2024-2029)
Table 26. North America Noninvasive Cancer Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Noninvasive Cancer Diagnostics Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Noninvasive Cancer Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Noninvasive Cancer Diagnostics Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Noninvasive Cancer Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Noninvasive Cancer Diagnostics Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Noninvasive Cancer Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Noninvasive Cancer Diagnostics Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Noninvasive Cancer Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Noninvasive Cancer Diagnostics Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Noninvasive Cancer Diagnostics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Noninvasive Cancer Diagnostics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Noninvasive Cancer Diagnostics as of 2022)
Table 39. Date of Key Players Enter into Noninvasive Cancer Diagnostics Market
Table 40. Global Noninvasive Cancer Diagnostics Key Players Headquarters and Area Served
Table 41. Noninvasive Cancer Diagnostics Product Solution and Service
Table 42. Global Noninvasive Cancer Diagnostics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Precision Therapeutics, Inc. (U.S.) Basic Information List
Table 45. Precision Therapeutics, Inc. (U.S.) Description and Business Overview
Table 46. Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Noninvasive Cancer Diagnostics Business of Precision Therapeutics, Inc. (U.S.) (2018-2023)
Table 48. Precision Therapeutics, Inc. (U.S.) Recent Developments
Table 49. A&G Pharmaceutical, Inc. (U.S.) Basic Information List
Table 50. A&G Pharmaceutical, Inc. (U.S.) Description and Business Overview
Table 51. A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Noninvasive Cancer Diagnostics Business of A&G Pharmaceutical, Inc. (U.S.) (2018-2023)
Table 53. A&G Pharmaceutical, Inc. (U.S.) Recent Developments
Table 54. Affymetrix Inc. (U.S.) Basic Information List
Table 55. Affymetrix Inc. (U.S.) Description and Business Overview
Table 56. Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Noninvasive Cancer Diagnostics Business of Affymetrix Inc. (U.S.) (2018-2023)
Table 58. Affymetrix Inc. (U.S.) Recent Developments
Table 59. AVIVA Biosciences Corporation (U.S.) Basic Information List
Table 60. AVIVA Biosciences Corporation (U.S.) Description and Business Overview
Table 61. AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Noninvasive Cancer Diagnostics Business of AVIVA Biosciences Corporation (U.S.) (2018-2023)
Table 63. AVIVA Biosciences Corporation (U.S.) Recent Developments
Table 64. BIOVIEW Inc. (U.S.) Basic Information List
Table 65. BIOVIEW Inc. (U.S.) Description and Business Overview
Table 66. BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Noninvasive Cancer Diagnostics Business of BIOVIEW Inc. (U.S.) (2018-2023)
Table 68. BIOVIEW Inc. (U.S.) Recent Developments
Table 69. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Basic Information List
Table 70. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Description and Business Overview
Table 71. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Noninvasive Cancer Diagnostics Business of Laboratory Corporation of America Holdings (LabCorp) (U.S.) (2018-2023)
Table 73. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Recent Developments
Table 74. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Basic Information List
Table 75. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Description and Business Overview
Table 76. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Noninvasive Cancer Diagnostics Business of Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) (2018-2023)
Table 78. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Recent Developments
Table 79. Digene Corporation (U.S.) Basic Information List
Table 80. Digene Corporation (U.S.) Description and Business Overview
Table 81. Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Noninvasive Cancer Diagnostics Business of Digene Corporation (U.S.) (2018-2023)
Table 83. Digene Corporation (U.S.) Recent Developments
Table 84. Gen-Probe Incorporated (U.S.) Basic Information List
Table 85. Gen-Probe Incorporated (U.S.) Description and Business Overview
Table 86. Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Noninvasive Cancer Diagnostics Business of Gen-Probe Incorporated (U.S.) (2018-2023)
Table 88. Gen-Probe Incorporated (U.S.) Recent Developments
Table 89. IVDiagnostics, Inc. (U.S.) Basic Information List
Table 90. IVDiagnostics, Inc. (U.S.) Description and Business Overview
Table 91. IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Products, Services and Solutions
Table 92. Revenue (US$ Million) in Noninvasive Cancer Diagnostics Business of IVDiagnostics, Inc. (U.S.) (2018-2023)
Table 93. IVDiagnostics, Inc. (U.S.) Recent Developments
Table 94. North America Noninvasive Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 95. North America Noninvasive Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 96. Europe Noninvasive Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 97. Europe Noninvasive Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 98. Asia-Pacific Noninvasive Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 99. Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 100. Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 101. Asia-Pacific Noninvasive Cancer Diagnostics Market Share by Region (2018-2023)
Table 102. Asia-Pacific Noninvasive Cancer Diagnostics Market Share by Region (2024-2029)
Table 103. Latin America Noninvasive Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Latin America Noninvasive Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 105. Latin America Noninvasive Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 106. Middle East & Africa Noninvasive Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 107. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 108. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 109. Noninvasive Cancer Diagnostics Market Trends
Table 110. Noninvasive Cancer Diagnostics Market Drivers
Table 111. Noninvasive Cancer Diagnostics Market Challenges
Table 112. Noninvasive Cancer Diagnostics Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Noninvasive Cancer Diagnostics Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Noninvasive Cancer Diagnostics Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Noninvasive Cancer Diagnostics Market Share by Regions: 2022 VS 2029
Figure 4. Global Noninvasive Cancer Diagnostics Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Noninvasive Cancer Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Noninvasive Cancer Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Noninvasive Cancer Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Noninvasive Cancer Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Noninvasive Cancer Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Clinical Chemistry
Figure 11. Global Clinical Chemistry Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Immunochemistry/Immunoassay
Figure 13. Global Immunochemistry/Immunoassay Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Molecular Diagnostics
Figure 15. Global Molecular Diagnostics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Others
Figure 17. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Global Noninvasive Cancer Diagnostics Market Size Share by Type: 2022 & 2029
Figure 19. North America Noninvasive Cancer Diagnostics Revenue Market Share by Type (2018-2029)
Figure 20. Europe Noninvasive Cancer Diagnostics Revenue Market Share by Type (2018-2029)
Figure 21. Asia-Pacific Noninvasive Cancer Diagnostics Revenue Market Share by Type (2018-2029)
Figure 22. Latin America Noninvasive Cancer Diagnostics Revenue Market Share by Type (2018-2029)
Figure 23. Middle East and Africa Noninvasive Cancer Diagnostics Revenue Market Share by Type (2018-2029)
Figure 24. Solid Tumors Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Blood Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 26. Lung Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Breast Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 28. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 29. Global Noninvasive Cancer Diagnostics Market Size Share by Application: 2022 & 2029
Figure 30. North America Noninvasive Cancer Diagnostics Revenue Market Share by Application (2018-2029)
Figure 31. Europe Noninvasive Cancer Diagnostics Revenue Market Share by Application (2018-2029)
Figure 32. Asia-Pacific Noninvasive Cancer Diagnostics Revenue Market Share by Application (2018-2029)
Figure 33. Latin America Noninvasive Cancer Diagnostics Revenue Market Share by Application (2018-2029)
Figure 34. Middle East and Africa Noninvasive Cancer Diagnostics Revenue Market Share by Application (2018-2029)
Figure 35. Noninvasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 36. Global Top 5 and Top 10 Players Noninvasive Cancer Diagnostics Market Share in 2022
Figure 37. North America Noninvasive Cancer Diagnostics Market Share by Country (2018-2029)
Figure 38. U.S. Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 39. Canada Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 40. Germany Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 41. France Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 42. U.K. Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 43. Italy Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 44. Russia Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 45. Nordic Countries Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 46. Asia-Pacific Noninvasive Cancer Diagnostics Market Share by Region (2018-2029)
Figure 47. China Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 48. Japan Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 49. South Korea Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 50. Southeast Asia Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 51. India Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 52. Australia Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 53. Latin America Noninvasive Cancer Diagnostics Market Share by Country (2018-2029)
Figure 54. Mexico Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 55. Brazil Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 56. Middle East & Africa Noninvasive Cancer Diagnostics Market Share by Country (2018-2029)
Figure 57. Turkey Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 59. UAE Noninvasive Cancer Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report